Fig. 3
From: Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Bivalent mRNA vaccination induces neutralizing activity against SARS-CoV-2 variant pseudoviruses. A Mouse model immunization and blood sample collection schedules. B–G Pseudovirus neutralization assay on serum collected from mice receiving monovalent or bivalent mRNA vaccination against wild-type (WT), Alpha, Delta, BA.5, BF.7, and BQ.1.1 pseudoviruses. H Half-maximal inhibitory concentrations (IC50) values for serum of monovalent or bivalent mRNA-vaccinated mouse against SARS-CoV-2 variant pseudoviruses. All experiments were performed in triplicate; standard deviations are shown as error bars